PSG5 and acute myeloid leukemia: Significantly, differences of PSG5 (a putative AF (Amniotic fluid)-MSC markers [25]) and SLC5A3 (essential to support a myo-inositol auxotrophy in AML [26]) were expressed in various stages of MDS in these data.